Literature DB >> 16533656

A hypothesis on prion disorders: are infectious, inherited, and sporadic causes so distinct?

F Fornai1, M Ferrucci, M Gesi, A Bandettini di Poggio, F S Giorgi, F Biagioni, A Paparelli.   

Abstract

Prion diseases include a group of either sporadic, inherited or infectious disorders characterized by spongiform neurodegeneration and reactive glyosis in several brain regions. Whatever the origin, the neuropathological hallmark of prion diseases is the presence of brain aggregates containing an altered isoform of a cellular protein, named prion protein. Recent findings show the potential toxicity of the normal cellular prion protein, which occurs when its physiological metabolism is altered. In particular, several studies demonstrate that accumulation of the prion protein in the cytosol can be a consequence of an increased amount of misfolded prion proteins, a derangement of the correct protein trafficking or a reduced activity of the ubiquitin-proteasome system. The same effects can be a consequence of a mutation in the gene coding for the prion protein. In all these conditions, one assists to accumulation and self-replication of insoluble prion proteins which leads to a severe disease resembling what observed following typical "prion infections". This article provides an opinion aimed at reconciling the classic Prusiner's theory concerning the "prion concepts" with the present knowledge arising from experimental studies on neurodegenerative disorders, suggesting a few overlapping steps in the pathogenesis of these diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533656     DOI: 10.1016/j.brainresbull.2005.12.005

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  10 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

Review 2.  Transmission of prions within the gut and towards the central nervous system.

Authors:  Gianfranco Natale; Michela Ferrucci; Gloria Lazzeri; Antonio Paparelli; Francesco Fornai
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

Review 3.  The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations.

Authors:  Filippo Sean Giorgi; Francesca Biagioni; Paola Lenzi; Alessandro Frati; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

Review 4.  Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

Authors:  Chi-Tso Chiu; De-Maw Chuang
Journal:  Pharmacol Ther       Date:  2010-08-10       Impact factor: 12.310

Review 5.  The ubiquitin-proteasome system in spongiform degenerative disorders.

Authors:  Brandi R Whatley; Lian Li; Lih-Shen Chin
Journal:  Biochim Biophys Acta       Date:  2008-08-23

6.  Protein aggregation and polyasparagine-mediated cellular toxicity in Saccharomyces cerevisiae.

Authors:  Theodore W Peters; Mingxia Huang
Journal:  Prion       Date:  2007-04-26       Impact factor: 3.931

7.  The variant Creutzfeldt-Jakob Disease: Risk, uncertainty or safety in the use of blood and blood derivatives?

Authors:  Antonio Liras
Journal:  Int Arch Med       Date:  2008-06-23

Review 8.  Prion Protein in Glioblastoma Multiforme.

Authors:  Larisa Ryskalin; Carla L Busceti; Francesca Biagioni; Fiona Limanaqi; Pietro Familiari; Alessandro Frati; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2019-10-15       Impact factor: 5.923

9.  The G127V variant of the prion protein interferes with dimer formation in vitro but not in cellulo.

Authors:  Sudheer Babu Sangeetham; Anna Dorothee Engelke; Jörg Tatzelt; Ervin Welker; Elfrieda Fodor; Sarah Laura Krausz
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

10.  Structural basis for the complete resistance of the human prion protein mutant G127V to prion disease.

Authors:  Zhen Zheng; Meilan Zhang; Yongheng Wang; Rongsheng Ma; Chenyun Guo; Liubin Feng; Jihui Wu; Hongwei Yao; Donghai Lin
Journal:  Sci Rep       Date:  2018-09-04       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.